The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic ...

Paul Curran, MPharm, a clinical pharmacist with Optimal You in the UK, says there is one nasty side effect, in particular, ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Wegovy, Mounjaro, and Ozempic are viral TikTok sensations. But the societal impact can’t be measured in views. Michael Edenfield’s doctor calls him the Incredible Shrinking Man. Between ...

Saxenda is a daily injection and Wegovy, like Mounjaro, is a weekly injection. Mounjaro has shown more promising results, with a clinical trial finding participants lost up to 22.5% of their body fat.

Wegovy, which was approved in 2021 for obesity, contains the same key ingredient as Ozempic, called semaglutide, while Mounjaro uses a slightly different one, tirzepatide.

A new Mounjaro user has opened up on their experience taking the drug - including the one side effect they're struggling with ...